MEND™ ENTERS AUSTRALIAN MARKET TO SUPPORT EVIDENCE-BASED RECOVERY FOR MUSCULOSKELETAL PATIENTS
19 August, Sydney, Australia – Clinical nutrition and musculoskeletal health company, mend™ Asia Pacific, has officially launched in Australia, introducing a purpose-built clinical nutrition product, mend™ Repair & Recover Surgery, to support musculoskeletal recovery through healthcare providers and surgical clinics.
Musculoskeletal conditions are one of the biggest contributors to healthcare costs and lost productivity in Australia. With one in three Australians expected to undergo surgery in their lifetime, there’s growing demand for solutions that support faster, more complete recovery.
Goran Petrovic, CEO of mend™ Asia Pacific, says, “Injury recovery shouldn’t be a black box – patients deserve clear, connected, and personalised support at every step of the journey. Everything about mend™ has been purpose-built for this region, from local formulation, manufacturing, and testing, through to how we engage with surgeons and clinics. Our long-term vision is to position Asia Pacific as a hub for product-driven recovery solutions that lift standards of care across the board.”
mend™ Repair & Recover Surgery is purpose-built for the Australian market to optimise surgical recovery. Formulated to preserve muscle mass, support tissue repair, enhance immunity, and help manage inflammation, it provides patients with the nutritional foundation to heal stronger and recover faster
It addresses a longstanding gap in the recovery journey, where patients are often discharged without structured, evidence-based nutritional support. Patients using mend™ recover stronger, with less fatigue, and return to normal daily function faster.
The formulation includes clinically backed ingredients such as HMB, whey protein, creatine, citrulline, arginine, and omega‑3s, key nutrients shown to support muscle preservation, tissue repair, and overall healing, setting mend™ apart from generic nutritional supplements.
By partnering with leading hospitals, clinicians, and universities globally, mend™ aims to deliver evidence-based solutions that support surgical and injury recovery. With over 20 orthopaedic surgeons from early adopter hospitals already signed on to offer mend™ to their patients, the demand is clearly there for smarter, practical, evidence-based recovery support.
Dr Josh Petterwood, orthopaedic surgeon and Chief Medical Advisor (APAC) at Zimmer Biomet, says, “As both a clinician and someone immersed in global orthopaedic and medtech innovation, I see first-hand how disconnected the recovery process can be once a patient leaves the hospital. mend™ is a product-driven solution that fills this gap – it’s practical, clinically sound, and built for the Australian healthcare system. It has the potential to significantly lift recovery outcomes across the board.”
mend™ Asia Pacific’s initial rollout will focus on partnering with private hospitals, surgical clinics, and sports medicine practices. The business is also working closely with leading clinicians and researchers to ensure product development continues to meet the evolving needs of both patients and the healthcare system.
Healthcare clinics can learn more about how mend™ supports recovery and patient outcomes here https://www.mendnutrition.au.
